All three have argued that manufacturers' only option is to refuse ... and anticoagulant Xarelto (rivaroxaban), and BMS' blood thinner Eliquis (apixaban) are among the 10 medicines elected for ...

“The first 10 drugs contained many that looked nothing like this—notably Xarelto and Eliquis ... Subsidizing other countries or U.S. drug manufacturers and their research and development teams is not ...

The Company is one of the major manufacturers of Pharma Intermediates for certain key APIs, including Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban. The Company Implemented the ...

Analysts having coverage on drug manufacturer Lupin Ltd. on Monday ... It said the company's announcement of generic Rivaroxaban 2.5 mg (Xarelto 2.5mg) tablets in the US is an "at risk" launch as the ...

The use of rivaroxaban 15 mg instead of the standard 20 mg/day ... Of note, as an investigator-sponsored research programme, the manufacturer (Shanghai Pushi Medical Instrument) of the LACbes occluder ...

These include: apixaban rivaroxaban edoxaban dabigatran injectable anticoagulants ... The person can administer these by subcutaneous injection. Manufacturers recommend rotating the site of ...

At three months of follow-up, patients hospitalized for a serious heart attack who were treated with the oral blood thinner ...

Rivaroxaban belongs to a newer class of drugs known as direct oral anticoagulants. As its blood-thinning effects are more predictable than those of warfarin, patients taking rivaroxaban don't need ...

Lupin is introducing rivaroxaban tablets, 2.5 mg, which is the generic of Janssen’s Xarelto. The medication is used to reduce the risk of major cardiovascular events in patients with coronary ...

CHICAGO, IL—Patients who develop thrombus in the left ventricle following myocardial infarction fare equally well when treated with rivaroxaban (Xarelto; Bayer/Janssen) as they do with warfarin, the ...